Do analysts recommend OWLT or ELUT?

Owlet presently has a consensus price target of $15.00, suggesting a potential upside of 217.80%. Given Owlet's stronger consensus rating and higher probable upside, equities analysts plainly believe Owlet is more favorable than Elutia. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Owlet 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40 Elutia 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher valuation and earnings, OWLT or ELUT?

Elutia has lower revenue, but higher earnings than Owlet. Owlet is trading at a lower price-to-earnings ratio than Elutia, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Owlet $105.70M 1.30 -$39.68M -$0.75 N/A Elutia $12.14M 3.00 $53.38M $0.95 0.87

Is OWLT or ELUT more profitable?

Elutia has a net margin of 426.93% compared to Owlet's net margin of -8.61%. Elutia's return on equity of -407.37% beat Owlet's return on equity. Company Net Margins Return on Equity Return on Assets Owlet -8.61% -601.24% -15.96% Elutia 426.93% -407.37% -47.08%

Does the media prefer OWLT or ELUT?

In the previous week, Owlet had 2 more articles in the media than Elutia. MarketBeat recorded 4 mentions for Owlet and 2 mentions for Elutia. Owlet's average media sentiment score of 0.93 beat Elutia's score of 0.91 indicating that Owlet is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Owlet 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Elutia 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is KRMD or ELUT more profitable?

Elutia has a net margin of 426.93% compared to KORU Medical Systems' net margin of -4.03%. KORU Medical Systems' return on equity of -10.63% beat Elutia's return on equity. Company Net Margins Return on Equity Return on Assets KORU Medical Systems -4.03% -10.63% -6.51% Elutia 426.93% -407.37% -47.08%

Do analysts rate APYX or ELUT?

Apyx Medical currently has a consensus target price of $6.50, indicating a potential upside of 150.97%. Given Apyx Medical's stronger consensus rating and higher possible upside, equities research analysts plainly believe Apyx Medical is more favorable than Elutia. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Apyx Medical 1 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.75 Elutia 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is APYX or ELUT more profitable?

Elutia has a net margin of 426.93% compared to Apyx Medical's net margin of -14.78%. Apyx Medical's return on equity of -76.60% beat Elutia's return on equity. Company Net Margins Return on Equity Return on Assets Apyx Medical -14.78% -76.60% -13.91% Elutia 426.93% -407.37% -47.08%

Do analysts recommend CNXU or ELUT?

Conexeu Sciences currently has a consensus price target of $20.00, indicating a potential upside of 414.14%. Given Conexeu Sciences' stronger consensus rating and higher probable upside, analysts clearly believe Conexeu Sciences is more favorable than Elutia. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Conexeu Sciences 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Elutia 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is CNXU or ELUT more profitable?

Elutia has a net margin of 426.93% compared to Conexeu Sciences' net margin of 0.00%. Conexeu Sciences' return on equity of -200.20% beat Elutia's return on equity. Company Net Margins Return on Equity Return on Assets Conexeu Sciences N/A -200.20% -177.26% Elutia 426.93% -407.37% -47.08%

Does the media refer more to CNXU or ELUT?

In the previous week, Conexeu Sciences had 3 more articles in the media than Elutia. MarketBeat recorded 5 mentions for Conexeu Sciences and 2 mentions for Elutia. Elutia's average media sentiment score of 0.91 beat Conexeu Sciences' score of 0.48 indicating that Elutia is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Conexeu Sciences 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Elutia 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate KEQU or ELUT?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Kewaunee Scientific 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Elutia 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media prefer KEQU or ELUT?

In the previous week, Kewaunee Scientific and Kewaunee Scientific both had 2 articles in the media. Kewaunee Scientific's average media sentiment score of 1.28 beat Elutia's score of 0.91 indicating that Kewaunee Scientific is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Kewaunee Scientific 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Elutia 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Elutia (ELUT) Competitors

$0.79 -0.03 (-4.02%)

As of 04:00 PM Eastern

Compare

ELUT vs. OWLT, KRMD, APYX, CNXU, and KEQU

Should you buy Elutia stock or one of its competitors? Elutia's main competitors and comparable companies include Owlet (OWLT), KORU Medical Systems (KRMD), Apyx Medical (APYX), Conexeu Sciences (CNXU), and Kewaunee Scientific (KEQU). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Elutia compare to Owlet?

Owlet (NYSE:OWLT) and Elutia (NASDAQ:ELUT) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership and risk.

72.6% of Owlet shares are owned by institutional investors. Comparatively, 74.0% of Elutia shares are owned by institutional investors. 36.2% of Owlet shares are owned by insiders. Comparatively, 17.8% of Elutia shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Owlet has a beta of 1.91, indicating that its stock price is 91% more volatile than the broader market. Comparatively, Elutia has a beta of 0.84, indicating that its stock price is 16% less volatile than the broader market.

Owlet presently has a consensus price target of $15.00, suggesting a potential upside of 217.80%. Given Owlet's stronger consensus rating and higher probable upside, equities analysts plainly believe Owlet is more favorable than Elutia.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Owlet	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Elutia	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Elutia has a net margin of 426.93% compared to Owlet's net margin of -8.61%. Elutia's return on equity of -407.37% beat Owlet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Owlet	-8.61%	-601.24%	-15.96%
Elutia	426.93%	-407.37%	-47.08%

In the previous week, Owlet had 2 more articles in the media than Elutia. MarketBeat recorded 4 mentions for Owlet and 2 mentions for Elutia. Owlet's average media sentiment score of 0.93 beat Elutia's score of 0.91 indicating that Owlet is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Owlet	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Elutia	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Elutia has lower revenue, but higher earnings than Owlet. Owlet is trading at a lower price-to-earnings ratio than Elutia, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Owlet	$105.70M	1.30	-$39.68M	-$0.75	N/A
Elutia	$12.14M	3.00	$53.38M	$0.95	0.87

Summary

Owlet beats Elutia on 9 of the 16 factors compared between the two stocks.

How does Elutia compare to KORU Medical Systems?

KORU Medical Systems (NASDAQ:KRMD) and Elutia (NASDAQ:ELUT) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, institutional ownership, valuation, earnings, risk, profitability and dividends.

58.6% of KORU Medical Systems shares are owned by institutional investors. Comparatively, 74.0% of Elutia shares are owned by institutional investors. 18.5% of KORU Medical Systems shares are owned by insiders. Comparatively, 17.8% of Elutia shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

KORU Medical Systems currently has a consensus price target of $7.00, indicating a potential upside of 136.49%. Given KORU Medical Systems' stronger consensus rating and higher probable upside, equities research analysts plainly believe KORU Medical Systems is more favorable than Elutia.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KORU Medical Systems	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.83
Elutia	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Elutia had 1 more articles in the media than KORU Medical Systems. MarketBeat recorded 2 mentions for Elutia and 1 mentions for KORU Medical Systems. KORU Medical Systems' average media sentiment score of 1.79 beat Elutia's score of 0.91 indicating that KORU Medical Systems is being referred to more favorably in the media.

Company	Overall Sentiment
KORU Medical Systems	Very Positive
Elutia	Positive

Elutia has a net margin of 426.93% compared to KORU Medical Systems' net margin of -4.03%. KORU Medical Systems' return on equity of -10.63% beat Elutia's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
KORU Medical Systems	-4.03%	-10.63%	-6.51%
Elutia	426.93%	-407.37%	-47.08%

KORU Medical Systems has a beta of 0.39, indicating that its share price is 61% less volatile than the broader market. Comparatively, Elutia has a beta of 0.84, indicating that its share price is 16% less volatile than the broader market.

Elutia has lower revenue, but higher earnings than KORU Medical Systems. KORU Medical Systems is trading at a lower price-to-earnings ratio than Elutia, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
KORU Medical Systems	$45.11M	3.01	-$2.64M	-$0.04	N/A
Elutia	$12.14M	3.00	$53.38M	$0.95	0.87

Summary

KORU Medical Systems beats Elutia on 10 of the 17 factors compared between the two stocks.

How does Elutia compare to Apyx Medical?

Apyx Medical (NASDAQ:APYX) and Elutia (NASDAQ:ELUT) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, profitability, earnings, risk, media sentiment, institutional ownership and valuation.

Apyx Medical currently has a consensus target price of $6.50, indicating a potential upside of 150.97%. Given Apyx Medical's stronger consensus rating and higher possible upside, equities research analysts plainly believe Apyx Medical is more favorable than Elutia.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.75
Elutia	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

55.3% of Apyx Medical shares are held by institutional investors. Comparatively, 74.0% of Elutia shares are held by institutional investors. 15.9% of Apyx Medical shares are held by company insiders. Comparatively, 17.8% of Elutia shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Apyx Medical has a beta of 1.45, suggesting that its stock price is 45% more volatile than the broader market. Comparatively, Elutia has a beta of 0.84, suggesting that its stock price is 16% less volatile than the broader market.

Elutia has lower revenue, but higher earnings than Apyx Medical. Apyx Medical is trading at a lower price-to-earnings ratio than Elutia, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Apyx Medical	$52.84M	2.06	-$11.21M	-$0.20	N/A
Elutia	$12.14M	3.00	$53.38M	$0.95	0.87

In the previous week, Elutia had 1 more articles in the media than Apyx Medical. MarketBeat recorded 2 mentions for Elutia and 1 mentions for Apyx Medical. Apyx Medical's average media sentiment score of 1.79 beat Elutia's score of 0.91 indicating that Apyx Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Apyx Medical	Very Positive
Elutia	Positive

Elutia has a net margin of 426.93% compared to Apyx Medical's net margin of -14.78%. Apyx Medical's return on equity of -76.60% beat Elutia's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Apyx Medical	-14.78%	-76.60%	-13.91%
Elutia	426.93%	-407.37%	-47.08%

Summary

Apyx Medical beats Elutia on 9 of the 17 factors compared between the two stocks.

How does Elutia compare to Conexeu Sciences?

Conexeu Sciences (NASDAQ:CNXU) and Elutia (NASDAQ:ELUT) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, institutional ownership, risk, profitability and earnings.

Elutia has a net margin of 426.93% compared to Conexeu Sciences' net margin of 0.00%. Conexeu Sciences' return on equity of -200.20% beat Elutia's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Conexeu Sciences	N/A	-200.20%	-177.26%
Elutia	426.93%	-407.37%	-47.08%

74.0% of Elutia shares are owned by institutional investors. 17.8% of Elutia shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Elutia has higher revenue and earnings than Conexeu Sciences. Conexeu Sciences is trading at a lower price-to-earnings ratio than Elutia, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Conexeu Sciences	N/A	N/A	-$3.92M	-$0.40	N/A
Elutia	$12.14M	3.00	$53.38M	$0.95	0.87

Conexeu Sciences currently has a consensus price target of $20.00, indicating a potential upside of 414.14%. Given Conexeu Sciences' stronger consensus rating and higher probable upside, analysts clearly believe Conexeu Sciences is more favorable than Elutia.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Conexeu Sciences	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Elutia	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Conexeu Sciences had 3 more articles in the media than Elutia. MarketBeat recorded 5 mentions for Conexeu Sciences and 2 mentions for Elutia. Elutia's average media sentiment score of 0.91 beat Conexeu Sciences' score of 0.48 indicating that Elutia is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Conexeu Sciences	0 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Elutia	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Elutia beats Conexeu Sciences on 9 of the 14 factors compared between the two stocks.

How does Elutia compare to Kewaunee Scientific?

Kewaunee Scientific (NASDAQ:KEQU) and Elutia (NASDAQ:ELUT) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, valuation, risk, earnings, media sentiment and institutional ownership.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Kewaunee Scientific	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Elutia	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Elutia has lower revenue, but higher earnings than Kewaunee Scientific. Elutia is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Kewaunee Scientific	$282M	0.35	$9.62M	$2.76	12.24
Elutia	$12.14M	3.00	$53.38M	$0.95	0.87

In the previous week, Kewaunee Scientific and Kewaunee Scientific both had 2 articles in the media. Kewaunee Scientific's average media sentiment score of 1.28 beat Elutia's score of 0.91 indicating that Kewaunee Scientific is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Kewaunee Scientific	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Elutia	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Elutia has a net margin of 426.93% compared to Kewaunee Scientific's net margin of 2.97%. Kewaunee Scientific's return on equity of 11.61% beat Elutia's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Kewaunee Scientific	2.97%	11.61%	4.82%
Elutia	426.93%	-407.37%	-47.08%

Kewaunee Scientific has a beta of 0.76, suggesting that its share price is 24% less volatile than the broader market. Comparatively, Elutia has a beta of 0.84, suggesting that its share price is 16% less volatile than the broader market.

32.7% of Kewaunee Scientific shares are held by institutional investors. Comparatively, 74.0% of Elutia shares are held by institutional investors. 14.1% of Kewaunee Scientific shares are held by company insiders. Comparatively, 17.8% of Elutia shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Kewaunee Scientific beats Elutia on 7 of the 13 factors compared between the two stocks.

Get Elutia News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ELUT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ELUT vs. The Competition

Export

Metric	Elutia	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$34.86M	$5.56B	$7.26B	$13.21B
Dividend Yield	N/A	1.77%	2.53%	22.58%
P/E Ratio	0.83	25.89	275.67	25.84
Price / Sales	2.87	70.42	579.80	79.34
Price / Cash	N/A	32.56	27.30	36.12
Price / Book	1.21	6.02	10.85	6.10
Net Income	$53.38M	$146.14M	$3.50B	$380.59M
7 Day Performance	-4.21%	-0.64%	-2.06%	-2.29%
1 Month Performance	-2.84%	-2.17%	-4.80%	-4.18%
1 Year Performance	-11.57%	4.36%	6.18%	0.57%

Elutia Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ELUT Elutia	1.0937 of 5 stars	$0.79 -4.4%	N/A	-7.5%	$34.86M	$12.14M	0.83	180	Gap Down
OWLT Owlet	2.7847 of 5 stars	$4.74 -3.1%	$15.00 +216.5%	-45.2%	$138.50M	$105.70M	N/A	114	News Coverage
KRMD KORU Medical Systems	4.5659 of 5 stars	$2.98 -0.7%	$7.00 +134.9%	-31.0%	$136.87M	$41.13M	N/A	73	Positive News
APYX Apyx Medical	3.4424 of 5 stars	$2.55 flat	$6.50 +154.9%	-12.8%	$107.41M	$52.84M	N/A	205	Positive News
CNXU Conexeu Sciences	2.0288 of 5 stars	$3.64 -0.5%	$20.00 +449.5%	N/A	$102.68M	N/A	N/A	4	Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ELUT) was last updated on 10/12/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Elutia (ELUT) Competitors

ELUT vs. OWLT, KRMD, APYX, CNXU, and KEQU

How does Elutia compare to Owlet?

Summary

How does Elutia compare to KORU Medical Systems?

Summary

How does Elutia compare to Apyx Medical?

Summary

How does Elutia compare to Conexeu Sciences?

Summary

How does Elutia compare to Kewaunee Scientific?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ELUT vs. The Competition

Elutia Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Elutia (ELUT) Competitors

ELUT vs. OWLT, KRMD, APYX, CNXU, and KEQU

How does Elutia compare to Owlet?

Do insiders and institutionals hold more shares of OWLT or ELUT?

Which has more volatility and risk, OWLT or ELUT?

Do analysts recommend OWLT or ELUT?

Is OWLT or ELUT more profitable?

Does the media prefer OWLT or ELUT?

Which has higher valuation and earnings, OWLT or ELUT?

Summary

How does Elutia compare to KORU Medical Systems?

Do institutionals and insiders believe in KRMD or ELUT?

Do analysts recommend KRMD or ELUT?

Does the media prefer KRMD or ELUT?

Is KRMD or ELUT more profitable?

Which has more volatility & risk, KRMD or ELUT?

Which has stronger valuation and earnings, KRMD or ELUT?

Summary

How does Elutia compare to Apyx Medical?

Do analysts rate APYX or ELUT?

Do institutionals & insiders believe in APYX or ELUT?

Which has more risk & volatility, APYX or ELUT?

Which has stronger earnings and valuation, APYX or ELUT?

Does the media prefer APYX or ELUT?

Is APYX or ELUT more profitable?

Summary

How does Elutia compare to Conexeu Sciences?

Is CNXU or ELUT more profitable?

Do insiders & institutionals believe in CNXU or ELUT?

Which has higher valuation & earnings, CNXU or ELUT?

Do analysts recommend CNXU or ELUT?

Does the media refer more to CNXU or ELUT?

Summary

How does Elutia compare to Kewaunee Scientific?

Do analysts rate KEQU or ELUT?

Which has preferable earnings & valuation, KEQU or ELUT?

Does the media prefer KEQU or ELUT?

Is KEQU or ELUT more profitable?

Which has more volatility and risk, KEQU or ELUT?

Do insiders and institutionals believe in KEQU or ELUT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ELUT vs. The Competition

Elutia Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools